Previous studies suggest that angiotensin converting enzyme (ACE) inhi
bitors cause reversible acute renal failure (ARF) in patients with hyp
ertension, congestive heart failure (CHF), and renal disease. These pa
tients often receive diuretics concomitantly with ACE inhibitors. The
purpose of this study was to examine whether ACE inhibitors alone prod
uce ARF or whether they do so when used in combination with diuretics.
The medical records of patients taking ACE inhibitors without or with
diuretics were reviewed. Complete data from 74 patients were obtained
and the data were analyzed. These 74 patients had a diagnosis of hype
rtension, CHF or diabetes mellitus. BUN and serum creatinine values be
fore, during, and after discontinuation of ACE inhibitor therapy for a
mean period of 8.7 months were collected. Seventy-four patients were
divided into two groups: Group A (n = 41) patients who received ACE in
hibitors alone; Group B (n = 33) patients who received a combination o
f an ACE inhibitor and a diuretic. ARF developed in 1 of 41 (2.4%) Gro
up A patients compared to 11 of 33 (33%) Group B patients. This group
difference was highly significant (P < .001). In Group A, mean serum c
reatinine before (1.24 +/- .34 mg/dl) was identical to that 1.23 +/- .
33 mg/dl) after 8.7 months of ACE inhibitor therapy, whereas in Group
B, post-mean serum creatinine (3.11 +/- 2.27 mg/dl) was significantly
(P < .01) higher than pre-mean serum creatinine (1.65 +/- .85 mg/dl).
CHF patients had a higher rate of ARF than patients with other diagnos
es. Urinary electrolytes showed that 4 of 6 Group B patients had chlor
ide concentration less than 20 mEq/l. Renal function recovered to base
line upon discontinuation of combination therapy but saline infusion a
ppeared to enhance recovery. Therefore, this study suggests that diure
tics through sodium-volume depletion potentiate the effect of ACE inhi
bitors on the kidney to cause decreased renal function.